Clinical Trial Update: A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) [Phase 4]

View source ↗

Summary

REALYSE is a Phase 4 trial comparing RYBELSUS to other glucose-lowering tablets in adults with Type 2 diabetes. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rybelsus (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED